Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
CTMedic's Profile
Displaying 951-1000 of 1653 result(s).
CYDY CytoDyn Inc
10/15/2020 11:35:18 PM
nmbr1, There is no delay or diversi (1)
CYDY CytoDyn Inc
10/15/2020 11:32:43 PM
Trials are continued after interim (4)
CYDY CytoDyn Inc
10/15/2020 11:12:41 PM
Penniestodimes, That is certainly a (2)
CYDY CytoDyn Inc
10/15/2020 11:07:02 PM
Calstang, My enthusiasm is not stif
CYDY CytoDyn Inc
10/15/2020 10:22:44 PM
Handicapping CytoDyn’s (OTCMKTS: (5)
CYDY CytoDyn Inc
10/15/2020 10:14:01 PM
I guess my glass is substantially m (3)
CYDY CytoDyn Inc
10/15/2020 8:46:55 PM
CaptnAmerca, I just checked myself (6)
CYDY CytoDyn Inc
10/15/2020 7:26:34 PM
Captn, Did you listen to presentati (6)
CYDY CytoDyn Inc
10/15/2020 7:23:20 PM
Henry, I am not good at reading tea (6)
CYDY CytoDyn Inc
10/15/2020 2:27:37 PM
DrSeethamraju in CD10 isirv present (1)
CYDY CytoDyn Inc
10/15/2020 7:45:45 AM
Dr. Seethamraju stated, during his (3)
CYDY CytoDyn Inc
10/14/2020 9:58:58 PM
Flash, We will need a mailing addre
CYDY CytoDyn Inc
10/14/2020 8:26:19 PM
Wolf, I really don't know. I believ
CYDY CytoDyn Inc
10/14/2020 8:23:31 PM
JC, I agree. I assume that this is (5)
CYDY CytoDyn Inc
10/14/2020 4:31:14 PM
Everything takes longer than we hop (2)
CYDY CytoDyn Inc
10/14/2020 4:08:00 PM
Dr. Seethamraju stated 220 patients
CYDY CytoDyn Inc
10/14/2020 4:06:33 PM
Dr. Seethamraju stated in his prese (2)
CYDY CytoDyn Inc
10/14/2020 9:58:04 AM
Generactor, NP certainly may have g (4)
CYDY CytoDyn Inc
10/13/2020 6:25:01 AM
Rubraquercus, Very good point. Cyto (4)
CYDY CytoDyn Inc
10/13/2020 6:09:29 AM
expharmer, Exactly right! Lily and (4)
CYDY CytoDyn Inc
10/12/2020 8:49:53 PM
EnemyofPluto, It is important to re (12)
CYDY CytoDyn Inc
10/12/2020 10:28:47 AM
Bob, do you believe that the DSMC w
CYDY CytoDyn Inc
10/12/2020 7:51:47 AM
Hoops, Thanks for sharing. I did no (1)
CYDY CytoDyn Inc
10/12/2020 7:00:10 AM
Hoops, Ideally we can have a good v (1)
CYDY CytoDyn Inc
10/12/2020 6:40:51 AM
Another article (medrxiv pre-print) (2)
CYDY CytoDyn Inc
10/11/2020 6:34:14 AM
EnemyofPluto, I try not too specula (3)
CYDY CytoDyn Inc
10/10/2020 7:20:50 PM
Rubraquercus, Perhaps after all our (4)
CYDY CytoDyn Inc
10/10/2020 6:26:35 PM
Crispr likely to be more important (3)
CYDY CytoDyn Inc
10/10/2020 6:08:04 PM
Goosebumps, Crispy will solve disea (1)
CYDY CytoDyn Inc
10/10/2020 3:27:03 PM
CD12 is phase 3 (registrational) se (7)
CYDY CytoDyn Inc
10/10/2020 1:51:26 PM
Borel, A reminder from a statistici
CYDY CytoDyn Inc
10/10/2020 10:09:22 AM
Ohm20, In vitro inhibits SARS-cov2
CYDY CytoDyn Inc
10/10/2020 9:30:06 AM
Ohm, I have read that a large porti (4)
CYDY CytoDyn Inc
10/08/2020 8:15:02 PM
Echo, You are correct that clinical (4)
CYDY CytoDyn Inc
10/08/2020 2:19:58 PM
Onestep, very few would argue with (2)
CYDY CytoDyn Inc
10/08/2020 1:58:13 PM
The market reaction to Nader's word (6)
CYDY CytoDyn Inc
10/08/2020 1:40:20 PM
Deaths in the leronlimab arm count (1)
CYDY CytoDyn Inc
10/07/2020 4:42:43 PM
Cardamine, That is a really astute (1)
CYDY CytoDyn Inc
10/07/2020 4:40:20 PM
Generator, I guess you must have fo (7)
CYDY CytoDyn Inc
10/07/2020 4:29:34 PM
I don’t think NP has experience w (8)
CYDY CytoDyn Inc
10/07/2020 2:06:44 PM
Thrifty, I don’t have cable. If y
CYDY CytoDyn Inc
10/07/2020 2:02:41 PM
Jlang, I agree wholeheartedly. I un (1)
CYDY CytoDyn Inc
10/07/2020 11:59:51 AM
Cycl2R, It seems to me to be a bad
CYDY CytoDyn Inc
10/07/2020 11:53:02 AM
Rubraquercus, I appreciate the stat (4)
CYDY CytoDyn Inc
10/07/2020 11:49:05 AM
Onestep, I don’t know if you inte (2)
CYDY CytoDyn Inc
10/07/2020 11:23:48 AM
Rubraquercus, We have seen the data (2)
CYDY CytoDyn Inc
10/07/2020 11:13:20 AM
Peacekat, I truly don’t know. Cd1 (1)
CYDY CytoDyn Inc
10/07/2020 10:48:06 AM
I believe it is a paid virtual conf (2)
CYDY CytoDyn Inc
10/07/2020 10:46:15 AM
The data from CD10 was sufficient f (4)
CYDY CytoDyn Inc
10/07/2020 9:35:42 AM
TechGuru, Having to choose among th (1)
Go to page:
  • << First
  • < Previous
  • 19
  • 20
  • Next >

Recent Articles

  • Class Action Filed Against iRobot Corporation: What You Need to Know
  • Tesla Faces Class Action as It Expands Autonomous Driving Tech
  • Spectrum Pharmaceuticals Faces Class Action Suit Over Misleading Claims
  • Class Action Lawsuit Filed Against CTO Realty Growth, Inc.
  • Lockheed Martin Investors: Your Chance to Join Class Action Suit
  • Important Legal Steps for Neogen Corporation Investors
  • Barbara Corcoran Shares Insights on Trump's Sales Tactics
  • Luminar Technologies Faces Lawsuit: Investors Take Action
  • Navigating the Potential of RxSight Securities Lawsuit
  • Stock Market Analysis: Insight into Current Trends and Highlights
  • Understanding the Class Action Lawsuit Against RxSight, Inc.
  • Faruqi & Faruqi LLP Takes on Altimmune Securities Fraud Case
  • PepGen Investors Advised on Class Action Lawsuit Opportunities
  • Important Class Action Update for Replimune Investors
  • Investor Alert: Rocket Pharmaceuticals Class Action Details
  • Faruqi & Faruqi Calls Investors to Act on Sable Offshore Case
  • Fluor Corporation: Scrutiny Over Securities Misleading Claims
  • Apple Inc. Faces Legal Challenges Over Investor Trust Issues
  • Investors Urged to Act in Petco Class Action Lawsuit - WOOF
  • IRS Leadership Shake-Up: Scott Bessent Steps In Amid Change
  • US Air Force Utilizes Tesla Cybertrucks for Combat Simulations
  • Magid Gloves Recognized as Industry Leaders in Safety Gear
  • Learning from the Dotcom Era: Investing in Quality Stocks
  • Mastering Price Breakouts: Avoid Common Trading Pitfalls
  • Elon Musk and Bill Gates: A Stark Contrast in Wealth Fluctuations
  • Trade Desk Faces Major Challenges as Amazon's Ad Business Soars
  • Xauras Emerges as a Leader in the DeFi Lending Revolution
  • Financial Market Turbulence: Gold Tariffs and Earnings Impact
  • SALOMON Launches Unique Concept Store to Boost Retail in China
  • Tesla Launches Robotaxi Service in Texas, Competing with Uber
  • RoboSense Unveils Groundbreaking Active Camera at Robotics Event
  • Tegna's Stock Surges Amid Nexstar Acquisition Talks
  • India's Shift in Defense Strategy: Delays and Implications
  • Design a Workshop That Stays Safe, Efficient, and Flexible
  • Apple's Leadership Challenge in AI: A Crucial Turning Point
  • Texas Attorney General's Battle Against Democratic Defiance
  • Folqs Launches First-Day Colostrum Powder to Meet Rising Demand
  • AONMeetings Introduces Affordable Webinar Solutions for All
  • Neogen Corporation Investors Alert: Class Action Update Received
  • Investor Update: Hims & Hers Issues Legal Notice for Shareholders
  • Sable Offshore Investors: Act Now to Protect Your Rights
  • Investors Urged to Act: Flywire Corporation Class Action Update
  • Nvidia's H20 Chip Exports to China: A Pivotal Opportunity
  • Discover the Legacy of Savoy with Engaging Lecture Series
  • Upcoming Trump-Putin Summit in Alaska Sparks Market Activity
  • Elegoo Introduces Innovative Creator Fund to Support 3D Design
  • Elegoo Unveils Groundbreaking Creator Fund for Innovators
  • America's Progress Under President Trump's Leadership Explored
  • Legal Proceedings Update for Sarepta Therapeutics Investors
  • America's Bright Future: A Look at Trump's Recent Achievements
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site